Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3194211 | 0.97 | MEN1 (0.53) | MEN1KMT2ASMN1; SMN2USP2TSHR | |
| SCHEMBL13038585 | 0.87 | USP2 (0.51) | MEN1KMT2ASMN1; SMN2USP2TSHR | |
| SCHEMBL3190391 | 0.85 | MEN1 (0.68) | MEN1KMT2ASMN1; SMN2CYP2C19L3MBTL1 | |
| SCHEMBL15101846 | 0.84 | KMT2A (0.63) | MEN1KMT2AUSP2TSHRCYP3A4 | |
| SCHEMBL3201443 | 0.84 | KMT2A (0.63) | MEN1KMT2AUSP2TSHRCYP3A4 | |
| SCHEMBL13998009 | 0.80 | USP2 (0.57) | SMN1; SMN2USP2TSHRCYP3A4CYP2C19 | |
| SCHEMBL5520649 | 0.79 | SMN1; SMN2 (0.56) | MEN1KMT2ASMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL13983889 | 0.79 | MEN1 (0.44) | MEN1KMT2ASMN1; SMN2USP2TSHR | |
| SCHEMBL17547338 | 0.78 | TSHR (0.64) | USP2TSHRCYP3A4CYP2C19NPSR1 | |
| SCHEMBL3181082 | 0.76 | USP2 (0.57) | SMN1; SMN2USP2TSHRCYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180009949-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2018-01-11 | — | — | US | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-9315633-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-9315633-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-20160060377-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20160060377-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20160060400-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20160060400-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| EP-2990431-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | The Boeing Company (US) | 2016-03-02 | — | — | EP | disclosed |
| US-20080300374-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2008-12-04 | — | — | US | disclosed |
| US-20080300374-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009949-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | PARN, AADAC, PARG | MEN1 2295/4885KMT2A 1035/4885SMN1; SMN2 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.